Clinical Trial Update: Valproate for the Treatment of Residual Amblyopia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial at Boston Children's Hospital is evaluating valproate for residual amblyopia in Phase 1/2; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amblyopia

Drugs mentioned

• Valproate (valproate)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Amblyopia, Amblyopia Unilateral | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING